id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0656-1313,FDA,FDA-2011-N-0656,FDA ADUFA Meeting Transcript,Other,Transcript(s),2022-12-29T05:00:00Z,2022,12,2022-12-29T05:00:00Z,,2022-12-29T16:40:59Z,,0,0,090000648555f2dc
FDA-2011-N-0656-1312,FDA,FDA-2011-N-0656,ADUFA V Summary of Public Comments,Other,Summary (SUM),2022-12-29T05:00:00Z,2022,12,2022-12-29T05:00:00Z,,2022-12-29T16:40:53Z,,0,0,090000648555f695
FDA-2011-N-0656-1304,FDA,FDA-2011-N-0656,ADUFA Public Meeting Brief,Other,Brief,2022-12-16T05:00:00Z,2022,12,2022-12-19T05:00:00Z,,2022-12-19T06:05:30Z,,0,0,090000648553de89
FDA-2011-N-0656-1302,FDA,FDA-2011-N-0656,Animal Drug User Fee Act Meeting Agenda,Other,Agenda,2022-12-07T05:00:00Z,2022,12,2022-12-07T05:00:00Z,,2022-12-07T13:31:36Z,,0,0,090000648551f3e8
FDA-2011-N-0656-1300,FDA,FDA-2011-N-0656,Animal Drug User Fee Act; Public Meeting; Request for Comments,Notice,Request for Comments,2022-11-21T05:00:00Z,2022,11,2022-11-21T05:00:00Z,2022-12-20T04:59:59Z,2022-12-21T02:01:20Z,2022-25274,0,0,09000064854ef8f2
FDA-2011-N-0656-1299,FDA,FDA-2011-N-0656,ADUFA Reauthorization Letter,Other,Letter(s),2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2022-12-20T04:59:59Z,2022-11-18T19:56:27Z,,0,0,09000064854d4bec